Prevalence and prognostic significance of proteinuria in patients with lung cancer

Acta Oncologica

Volumn 35, Issue 6, 1996, Pages 691-695

  Pedersen, Lars Møller ^a,b   Milman, Nils ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ROSKILDE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; PATIENT MONITORING; PROTEINS; PULMONARY DISEASES;

CELL CARCINOMA; LUNG CANCER; PROTEINURIA; URINARY DIPSTICK TESTING;

ONCOLOGY;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LUNG CANCER; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA;

EID: 10344231430     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869609084000     Document Type: Article

References (36)

1. Eagen JW, Lewis E. Glomerulopathies of neoplasia. Kidney Int 1977; 11: 297-306.
2. Kaplan BS, Klassen J, Gault MH. Glomerular injury in patients with neoplasia. Annu Rev Med 1976; 27: 117-25.
3. Cameron JS, Ogg CS. Neoplastic disease and the nephrotic syndrome. Q J Med 1975; 44: 630-1.
4. Heaton JM, Menzin MA, Carney DN. Extrarenal malignancy and the nephrotic syndrome. J Clin Pathol 1975; 28: 944-6.
5. Jermanovich NB, Giammarco R, Ginsberg SJ, Tinsley RW, Jones DB. Small cell anaplastic carcinoma of the lung with mesangial proliferative glomerulonephritis. Arch Intern Med 1982; 142: 397-9.
6. Norris SH. Paraneoplastic glomerulopathies. Semin Nephrol 1993; 13: 258-72.
7. Mehmet FF, McKinney TD, Richardson RL, Hande KR, Oldham RK, Greco FA. Cancer and the kidney: Renal complications of neoplasms. Am J Med 1981; 71: 704-18.
8. Sawyer N, Wadsworth J, Wijnen M, Gabriel R. Prevalence, concentration, and prognostic importance of proteinuria in patients with malignancies. Br Med J 1988; 296: 1295-8.
9. Puolijoki H, Mustonen J, Pettersson E, Pasternack A, Lahdensuo A. Proteinuria and haematuria are frequently present in patients with lung cancer. Nephrol Dial Transplant 1989; 4: 947-50.
10. Rudman D, Rio A, Akgum S, Frumin E. Novel proteins and peptides in the urine of patients with advanced neoplastic disease. Am J Med 1969; 46: 174-87.
11. Hemmingsen L, Skaarup P. Urinary excretion of ten plasma proteins in patients with extrarenal epithelial carcinoma. Acta Chir Scand 1977; 143: 177-83.
12. Davison AM, Thomson D. Malignancy-associated glomerular disease. In: Cameron JS, Davison AM, Grunfeld J-P, et al., eds. Oxford Textbook of Clinical Nephrology. New York, NY: Oxford, 1992: 475-86.
13. Kannel WB, Stampfer MJ, Castelli WP, Verter J. The prognostic significance of proteinuria: the Framingham study. Am Heart J 1984; 108: 1347-52.
14. Histological typing of lung tumours. 2nd. ed. Geneva: World Health Organization, 1981.
15. Mountain CF. A new international staging system for lung cancer. Chest 1986; 89: 225-33.
16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
17. Peto R, Pike MC, Armitage R, et al. Design and analysis of clinical trials requiring prolonged observation of each patient. Br J Cancer 1977; 35: 1-47.
18. Cox DR. Regression model and life tables. J R Stat Soc (Series B) 1972; 34: 187-220.
19. Lee JR, Yamauchi H, Hopper J Jr. The association of cancer and nephrotic syndrome. Ann Intern Med 1966; 64: 41-51.
20. Brueggemeyer CD, Ramirez G. Membranous nephropathy: A concern for malignancy. Am J Kidney Dis 1987; 9: 23-6.
21. Pascal RR, Iannoccone PM, Rollwagen FM, Harding TA, Bennett SJ. Electron microscopy and immunofluorescence of glomerular immune complex deposits in cancer patients. Cancer Res 1976; 36: 43-7.
22. Mustonen J, Henn H, Pasternack A. IgA nephropathy associated with bronchial small cell carcinoma. Am J Clin Pathol 1981; 76: 652-6.
23. Savin VJ. Mechanisms of proteinuria in noninflammatory glomerular diseases. Am J Kidney Dis 1993; 21: 347-62.
24. Rossen RD, Reisberg MA, Singer D, et al. The effect of age on the character of immune complex disease: A comparison of the incidence and relative size of materials reactive with CIq in sera of patients with glomerulonephritis and cancer. Medicine 1979; 58: 65-79.
25. Olson JL, Philips TM, Lewis MG, Solez K. Malignant melanoma with renal dense deposits containing tumour antigens. Clin Nephrol 1979; 12: 74-82.
26. Costanza ME, Pinn V, Schwartz RS, Nathanson L. Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome. N Engl J Med 1973; 289: 520-2.
27. Beaufils H, Jouanneau C, Chomette G. Kidney and cancer: results of immunofluorescence microscopy. Nephron 1985; 40: 303-8.
28. Lewis MG, Loughridge LW, Philips TM. Immunological studies in nephrotic syndrome associated with extrarenal malignant disease. Lancet 1971; 2: 134-5.
29. Sutherland JC, Markham RV, Mardiney MR. Subclinical immune complexes in the glomeruli of kidneys postmortem. Am J Med 1974; 57: 536-41.
30. Glassock RJ, Cohen AH, Adler SG, et al. Secondary glomerular diseases. In: Brenner BM, Rector FC, eds. The Kidney. Philadelphia, PA: Saunders, 1991: 1280-368.
31. Alpers CE, Cotran RS. Neoplasia and glomerular injury. Kidney Int 1986; 30: 465-73.
32. Moorthy AV, Zimmerman SW, Burkholder PM. Nephrotic syndrome in Hodgkin's disease. Evidence for pathogenesis alternative to immune complex deposition. Am J Med 1976; 61: 471-7.
33. Shalhoub RJ, Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet 1974; 2: 556-9.
34. Gluck MC, Gallo G, Lowenstein J, Baldwin DS. Membranous glomerulonephritis. Evaluation of clinical and pathologic features. Ann Intern Med 1973; 78: 1-12.
35. Yamauchi H, Linsey MS, Maiava CG, et al. Cure of membranous nephropathy after resection of carcinoma. Arch Intern Med 1985; 145: 2061-3.
36. Froom DW, Franklin WA, Hano JE, Potter EV. Immune deposits in Hodgkin's disease with nephrotic syndrome. Arch Pathol Lab Med 1972; 94: 547-53.